NeuroPace, Inc.

NeuroPace, Inc.verified

NPCE

Price:

$11.28

Market Cap:

$336.69M

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.[Read more]

Industry

Medical - Devices

IPO Date

2021-04-22

Stock Exchange

NASDAQ

Ticker

NPCE

The Enterprise Value as of December 2024 (TTM) for NeuroPace, Inc. (NPCE) is 394.77M

According to NeuroPace, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 394.77M. This represents a change of 20.26% compared to the average of 328.25M of the last 4 quarters.

NeuroPace, Inc. (NPCE) Historical Enterprise Value (quarterly & annually)

How has NPCE Enterprise Value performed in the past?

The mean historical Enterprise Value of NeuroPace, Inc. over the last ten years is 394.50M. The current 394.77M Enterprise Value has changed 9.91% with respect to the historical average. Over the past ten years (40 quarters), NPCE's Enterprise Value was at its highest in in the March 2021 quarter at 594.45M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

394.50M

Median

320.87M

Minimum

99.81M

Maximum

653.43M

NeuroPace, Inc. (NPCE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NeuroPace, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 221.48%

Maximum Annual Enterprise Value = 653.43M

Minimum Annual Increase = -63.99%

Minimum Annual Enterprise Value = 99.81M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023320.87M221.48%
202299.81M-63.99%
2021277.15M-55.39%
2020621.23M-4.93%

NeuroPace, Inc. (NPCE) Average Enterprise Value

How has NPCE Enterprise Value performed in the past?

The current Enterprise Value of NeuroPace, Inc. (NPCE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

232.61M

5-year avg

394.50M

10-year avg

394.50M

NeuroPace, Inc. (NPCE) Enterprise Value vs. Peers

How is NPCE’s Enterprise Value compared to its peers?

NeuroPace, Inc.’s Enterprise Value is greater than Electromed, Inc. (228.97M), less than OrthoPediatrics Corp. (534.63M), less than Surmodics, Inc. (566.48M), less than Paragon 28, Inc. (911.19M), greater than Nevro Corp. (331.62M), less than NuVasive, Inc. (2.84B), less than Integer Holdings Corporation (5.81B), less than Glaukos Corporation (7.79B), less than CONMED Corporation (3.13B), greater than ProSomnus, Inc. Common Stock (40.81M), greater than Anika Therapeutics, Inc. (220.73M), less than Heska Corporation (1.26B), greater than Pulmonx Corporation (245.22M), less than IRadimed Corporation (635.19M), less than Orthofix Medical Inc. (818.73M), greater than CVRx, Inc. (277.35M), less than Artivion, Inc. (1.55B),

Build a custom stock screener for NeuroPace, Inc. (NPCE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroPace, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroPace, Inc. (NPCE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroPace, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is NeuroPace, Inc.'s Enterprise Value?

What is the highest Enterprise Value for NeuroPace, Inc. (NPCE)?

What is the 3-year average Enterprise Value for NeuroPace, Inc. (NPCE)?

What is the 5-year average Enterprise Value for NeuroPace, Inc. (NPCE)?

How does the current Enterprise Value for NeuroPace, Inc. (NPCE) compare to its historical average?